These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 8046598)

  • 21. Oral administration of [3H]navelbine in patients: comparative pharmacokinetics using radioactive and radioimmunologic determination methods.
    Rahmani R; Zhou XJ; Boré P; Van Cantfort J; Focan C; Cano JP
    Anticancer Drugs; 1991 Aug; 2(4):405-10. PubMed ID: 1797198
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Advances in vinca-alkaloids: Navelbine.
    Marty M; Extra JM; Espie M; Leandri S; Besenval M; Krikorian A
    Nouv Rev Fr Hematol (1978); 1989; 31(2):77-84. PubMed ID: 2671933
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Vinorelbine: a novel vinca alkaloid.
    Toso C; Lindley C
    Am J Health Syst Pharm; 1995 Jun; 52(12):1287-304; quizz 1340-1. PubMed ID: 7656116
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Direct determination of the driving forces for taurocholate uptake into rat liver plasma membrane vesicles.
    Duffy MC; Blitzer BL; Boyer JL
    J Clin Invest; 1983 Oct; 72(4):1470-81. PubMed ID: 6630516
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Kinetic analysis of combination effect of navelbine (KW-2307) with cisplatin against human lung adenocarcinoma PC-12 cells in culture.
    Gomi K; Ohno H; Nomura K; Okabe M; Kobayashi K; Niitani H
    Jpn J Cancer Res; 1992 May; 83(5):532-9. PubMed ID: 1618703
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Uptake of Vinca alkaloids into mammalian nerve and its subcellular components.
    Iqbal Z; Ochs S
    J Neurochem; 1980 Jan; 34(1):59-68. PubMed ID: 6161213
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Clinical pharmacokinetics of navelbine after oral administration, in vitro metabolism and interindividual variability].
    Sahnoun Z; Zhou XJ; Bore P; Monjanel S; Favre R; Durand A; Rahmani R
    Bull Cancer; 1990; 77(11):1115-21. PubMed ID: 2275987
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Energetics of vinca alkaloid interactions with tubulin isotypes: implications for drug efficacy and toxicity.
    Lobert S; Frankfurter A; Correia JJ
    Cell Motil Cytoskeleton; 1998; 39(2):107-21. PubMed ID: 9484953
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical pharmacokinetics of the antitumor drug navelbine (5'-noranhydrovinblastine).
    Rahmani R; Bruno R; Iliadis A; Favre R; Just S; Barbet J; Cano JP
    Cancer Res; 1987 Nov; 47(21):5796-9. PubMed ID: 3664483
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Uptake and metabolism of vinca alkaloids by freshly isolated human hepatocytes in suspension.
    Zhou XJ; Placidi M; Rahmani R
    Anticancer Res; 1994; 14(3A):1017-22. PubMed ID: 8074443
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pharmacokinetics of navelbine after oral administration in the dog and the monkey.
    Zhou XJ; Landi H; Breillout F; Rahmani R
    Anticancer Drugs; 1993 Aug; 4(4):511-5. PubMed ID: 8400355
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Antitumor activity of navelbine (vinorelbine ditartrate), a new vinca alkaloid analog].
    Ashizawa T; Miyoshi K; Asada M; Kobayashi E; Okabe M; Morimoto M; Gomi K; Hirata T
    Gan To Kagaku Ryoho; 1993 Jan; 20(1):59-66. PubMed ID: 8422187
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Preclinical and clinical pharmacology of vinca alkaloids.
    Zhou XJ; Rahmani R
    Drugs; 1992; 44 Suppl 4():1-16; discussion 66-9. PubMed ID: 1283846
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparative genotoxic effect of vincristine, vinblastine, and vinorelbine in somatic cells of Drosophila melanogaster.
    Tiburi M; Reguly ML; Schwartsmann G; Cunha KS; Lehmann M; Rodrigues de Andrade HH
    Mutat Res; 2002 Aug; 519(1-2):141-9. PubMed ID: 12160899
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Radioimmunoassay and preliminary pharmacokinetic studies in rats of 5'-noranhydrovinblastine (navelbine).
    Rahmani R; Martin M; Barbet J; Cano JP
    Cancer Res; 1984 Dec; 44(12 Pt 1):5609-13. PubMed ID: 6498821
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A study of the electrochemical oxidation of Navelbine.
    Brett AM; Grazina MM; Macedo TR; Oliveira C; Raimundo D
    J Pharm Biomed Anal; 1993 Mar; 11(3):203-6. PubMed ID: 8518318
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Vinorelbine induces apoptosis and caspase-3 (CPP32) expression in leukemia and lymphoma cells: a comparison with vincristine.
    Toh HC; Sun L; Koh CH; Aw SE
    Leuk Lymphoma; 1998 Sep; 31(1-2):195-208. PubMed ID: 9720729
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Concomitant decrease of resistance and modifications of the cytoskeleton after all-trans retinoic acid and phorbol ester treatments in a navelbine-resistant bladder carcinoma cell line.
    Debal V; Breillout F; Manfait M
    Anticancer Res; 1997; 17(2A):1147-54. PubMed ID: 9137463
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Daunorubicin and vincristine binding to plasma membrane vesicles from daunorubicin-resistant and wild type Ehrlich ascites tumor cells.
    Sehested M; Bindslev N; Demant EJ; Skovsgaard T; Jensen PB
    Biochem Pharmacol; 1989 Sep; 38(18):3017-27. PubMed ID: 2571333
    [TBL] [Abstract][Full Text] [Related]  

  • 40. ATP-dependent transport of the linear renin-inhibiting peptide EMD 51921 by canalicular plasma membrane vesicles of rat liver: evidence of drug-stimulatable ATP-hydrolysis.
    Ziegler K; Kolac C; Ising W
    Biochim Biophys Acta; 1994 Dec; 1196(2):209-17. PubMed ID: 7841185
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.